These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13173338)

  • 1. The clinical use of intravenous sodium para-aminosalicylate and polyvinyl pyrrolidone.
    WEISS W; SEVEN MJ
    Dis Chest; 1954 Jul; 26(1):47-51. PubMed ID: 13173338
    [No Abstract]   [Full Text] [Related]  

  • 2. The intravenous use of a combination of sodium para-aminosalicylate and polyvinyl pyrrolidone in the chemotherapy of tuberculosis.
    WEISS W; SEVEN M; EISENBERG GM
    Am J Med Sci; 1953 May; 225(5):560-4. PubMed ID: 13040342
    [No Abstract]   [Full Text] [Related]  

  • 3. The single daily dose of sodium para-aminosalicylic acid used in conjunction with streptomycin in tuberculosis.
    MARSDEN JA
    Med J Aust; 1954 Dec; 2(24):934-5. PubMed ID: 13223087
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of benemid to enhance blood-levels of sodium para-aminosalicylate (PAS).
    MCLEOD JA; TURNBULL FW; CROFTON JW
    Tubercle; 1953 Jun; 34(6):152-5. PubMed ID: 13077745
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxic psychiatric manifestations in the treatment of tuberculosis with sodium para-aminosalicylate.
    PUGH DL; EDWORDS GS; MCLAREN RG; JONES ER
    Tubercle; 1952 Dec; 33(12):369-76. PubMed ID: 13005721
    [No Abstract]   [Full Text] [Related]  

  • 6. Benemid and sodium PAS.
    SIMMONDS FA; HESS EV
    Tubercle; 1952 May; 33(5):138-42. PubMed ID: 14942897
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of rheumatoid and osteoarthritis by sodium para-aminosalicylate with presentation of cases.
    BROUS M
    Med J Aust; 1952 Jun; 1(23):774-6. PubMed ID: 14940204
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of rheumatoid arthritis and osteoarthritis by sodium para-aminosalicylate with presentation of cases.
    BROUS M
    Br J Phys Med; 1953 Jan; 16(1):1-3. PubMed ID: 13009065
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombocytopenia induced by administration of sodium para-aminosalicylate.
    GREGG JA; MAYOCK RL
    J Am Med Assoc; 1960 Apr; 172():1909-12. PubMed ID: 13851676
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical use of potassium para-aminosalicylate (KPAS).
    MOLTHAN L; COHEN RV; ZARAFONETIS CJ
    Am Rev Tuberc; 1955 Feb; 71(2):220-7. PubMed ID: 14350181
    [No Abstract]   [Full Text] [Related]  

  • 11. Reaction to streptomycin and to sodium para-aminosalicylate (PAS).
    MCLEOD JA
    N Z Med J; 1955 Oct; 54(303):555-9. PubMed ID: 13288813
    [No Abstract]   [Full Text] [Related]  

  • 12. The subcutaneous administration of the sodium salt of para-aminosalicylic acid in the treatment of tuberculosis.
    FISHER BM; ROBERTS G; HINSHAW HC
    Am Rev Tuberc; 1951 Nov; 64(5):557-63. PubMed ID: 14885687
    [No Abstract]   [Full Text] [Related]  

  • 13. [Circulation of sodium para-aminosalicylate in man and in animal].
    PELLERAT J; MARAL R; MURAT M; BLANDIN A; BRUGIRARD M
    Ann Biol Clin (Paris); 1950; 8(4):485-93. PubMed ID: 14790337
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined hypersensitivity reaction to sodium para-aminosalicylate and associated antibacterial drug concurrently administered.
    COHEN AA; LAWRENCE SH
    Ann Intern Med; 1957 May; 46(5):893-906. PubMed ID: 13411899
    [No Abstract]   [Full Text] [Related]  

  • 15. [COMMENTS ON 2 CASES OF SEVERE ALLERGIC REACTION TO SODIUM PARA-AMINOSALICYLATE (PAS)].
    POP E; NICULESCU M; ZAMFIRESCU E; NEGHINA S
    Med Interna (Bucur); 1964 Dec; 16():1493-6. PubMed ID: 14305643
    [No Abstract]   [Full Text] [Related]  

  • 16. [Final treatment of tuberculous caverns of the lung, in endocavitary aspiration, with a 40% solution of sodium para-aminosalicylate].
    GEMMI M
    Riforma Med; 1951 Jun; 65(22):603-8. PubMed ID: 14865697
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous sodium para-aminosalicylate].
    DOURIS RG; BORY J
    Therapie; 1951; 6(5):371-4. PubMed ID: 14922315
    [No Abstract]   [Full Text] [Related]  

  • 18. Polyvinylpyrrolidone as a drug retardant. III. Effect on sodium p-aminosalicylate.
    GRAHAM WD; TEED H
    J Pharm Pharmacol; 1954 Aug; 6(8):558-61. PubMed ID: 13184435
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic value of the addition of sodium benzoate to PAS in the treatment of tuberculosis; preliminary note].
    PARAF J; DESBORDES J; ROSENBERG E
    Bull Mem Soc Med Hop Paris; 1952 Jul 4-11; 68(24-25):912-4. PubMed ID: 12988032
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypopotassemia and hyponatremia in pulmonary tuberculosis during treatment with streptomycin and paraaminosalicylic acid.
    AMATUZIO DS; BREITENBUCHER RB; FALK A; STUTZMAN FL
    Am Rev Tuberc; 1952 Sep; 66(3):357-63. PubMed ID: 14952722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.